Multi-Omics Monitoring of Drug Response in Rheumatoid Arthritis in Pursuit of Molecular Remission

Nature Communications - United Kingdom
doi 10.1038/s41467-018-05044-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Patient’s Perspective of Sustained Remission in Rheumatoid Arthritis

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2017English

Morphometry for Early Monitoring of Treatment Response in Rheumatoid Arthritis

2013English

Drug-Free Remission: The Goal of the Future in Management of Patients With Rheumatoid Arthritis

Reumatologia
RheumatologyAllergyImmunology
2017English

Drug Trials in Rheumatoid Arthritis

InPharma
1980English

Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Predictors and Persistence of New-Onset Clinical Remission in Rheumatoid Arthritis Patients

Seminars in Arthritis and Rheumatism
RheumatologyAnesthesiologyPain Medicine
2013English

Adalimumab Discontinuation in Patients With Rheumatoid Arthritis After Achieving Sustained Remission

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2018English

Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2020English

AB0424 Il-6 Receptor Blockade Induced a Different Immune Response in Rheumatoid Arthritis Patients With and Without Remission

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy